These drugs fall within two categories: human GLP-1 backbone agents (that is, albiglutide, dulaglutide, liraglutide and semaglutide) and exendin-4 backbone agents (that is, exenatide, lixisenatide and tirzepatidethe latter activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors) 1
there is no evidence that Wegovy increases this risk
If youve missed several consecutive doses, contact your healthcare provider before resuming
The GLP-1 agonist slowing gastric emptying can affect the glucose peak from meals, which in turn affects insulin timing
Gary speaks from experience: I take mine on Sundays, and Im usually in the bathroom thinking, Oh, rightand then I head to the kitchen